We are international
Donate

Senior Grant Recipients

Nicola Giuliani

Study of Alterations of Bone Microenvironment Cells in MM Patients in Relationship with Osteolytic Bone Lesions: Identification of Potential New Therapeutic Targets

Nicola Giuliani, MD, PhD

Cattedra Di Ematologia
Universitaria Di Parma
Parma, Italy
 
Ruth Craig

Conversion of Antiapoptotic MCL1 to Death-inducing Forms in Multiple Myeloma

Ruth Craig, PhD
Dartmouth Medical School
Dept. of Pharmacology and Toxicology
Hanover, New Hampshire

Dr. Craig's research is funded by a grant from the Member FUNdraiser Afternoon Tea – Carol Klein and Nancy Moses


Junior Grant Recipients

Samantha Pozzi

Promoting Osteoblastogenesis with a Novel Clinical Grade Dkk-1 Neutralizing Antibody in the Treatment of Multiple Myeloma Related Bone Disease

Samantha Pozzi, MD
Dana Farber Cancer Institute, Massachusetts General Hospital
Dept. of Medical Oncology
Boston, Massachusetts

 

Loredana Santo

Preclinical Evaluation of a Novel Small Molecule Multi-cyclin Dependent Kinase Inhibitor, AT7519 in Multiple Myeloma

Loredana Santo, MD
Dana Farber Cancer Institute, Massachusetts General Hospital
Dept. of Medical Oncology
Boston, Massachusetts

 

Karin Vanderkerken

Targeting Multiple Myeloma with Nanobodies: Study in the 5TMM Model (2nd Year of Funding)

Karin Vanderkerken, Ph.D.
Vrije Universiteit Brussel (VUB)
Brussels, Belgium


IMF Japan AKI Award: in memory of IMF Japan Founder Akira (AKI) Horinouchi

Hiroyuki Shibata


Hiroyuki Shibata, MD
Tohoku University
Sendai, Japan